Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-3858.96	-4904.63	-123.89
Graham Fair Price	212.36	0.39	0.13
PEG	-98.08	-0.02	0.83
Price/Book	-24.19	7.22	9.53
Price/Cash Flow	-53.73	-27.91	-18.15
Prices/Earnings	-87.26	13.83	-108.58
Price/Sales	62.97	13.50	8.29
Price/FCF	-53.73	-27.91	-18.15
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-31.61	0.30	0.44
Operating Margin	6027.96	0.23	< 0.005
ROA	651.40	0.03	< 0.005
ROE	-0.02	0.13	495.08
ROIC	< 0.005	0.07	3030.19
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.09	-0.34	-72.75
Dividends QOQ	0.03	-0.34	1100.11
EBIT QOQ	-0.95	31.98	3275.23
EPS QOQ	-1.31	8.69	562.52
FCF QOQ	-10.68	0.43	-95.98
Revenue QOQ	0.86	-0.46	-46.30
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	145.79	209.24	43.52
Days Sales Outstanding (DSO)	106.44	141.74	33.17
Inventory Turnover	0.62	0.43	-30.32
Debt/Capitalization	0.56	0.55	-2.52
Quick Ratio	0.02	0.05	138.57
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	0.18	0.23	28.05
Cash	-0.23	-0.16	30.73
Capex	< 0.005	< 0.005	69.60
Free Cash Flow	-0.09	-0.06	36.85
Revenue	0.21	0.12	-40.43
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.70	0.75	8.43
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-9.45	-358.96	-3696.87
Naive Interpretation	Member

06 - Financial Health · Bad

Rating